Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
, , e
28 mar 2022
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 28 mar 2022
Pagine: 259 - 266
Ricevuto: 21 ott 2021
Accettato: 31 gen 2022
DOI: https://doi.org/10.2478/raon-2022-0010
Parole chiave
© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Borowicz, Dorota Maria
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Skrobała, Agnieszka
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Kruszyna-Mochalska, Marta
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Malicki, Julian
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland